Last reviewed · How we verify
Placebo of Test product
Placebo of Test product is a Small molecule drug developed by FLUIDDA nv. It is currently in Phase 3 development. Also known as: Placebo inhaler containing HFA propellant resembling the test active inhaler.
A placebo control product designed to match the appearance and administration route of FLUIDDA's test product for blinded clinical comparison.
At a glance
| Generic name | Placebo of Test product |
|---|---|
| Also known as | Placebo inhaler containing HFA propellant resembling the test active inhaler |
| Sponsor | FLUIDDA nv |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Placebos are inert formulations used in randomized controlled trials to establish the true efficacy of an investigational drug by comparison against a non-active control. This placebo is specifically formulated to match the test product's characteristics to maintain blinding integrity in the phase 3 trial.
Approved indications
Common side effects
Key clinical trials
- Adenosine 2A Receptor Antagonism and AIH in ALS (PHASE1, PHASE2)
- Effect of L. Reuteri LM1063 on Sleep Health Improvement (NA)
- MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial) (PHASE2)
- Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer (PHASE1, PHASE2)
- Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer (PHASE3)
- MP101 in Adults With Acute Pseudomonas Aeruginosa Pneumonia (PHASE1)
- A Phase Ia/Ib, First-in-human (FIH) Study for Safety, Tolerability, Pharmacokinetics (PK), and Clinical Activity Evaluation of ADEL-Y01 (PHASE1)
- Effectiveness of Topical Menthol as A Cooling Method During Exercise in A Recreational Runner Population (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo of Test product CI brief — competitive landscape report
- Placebo of Test product updates RSS · CI watch RSS
- FLUIDDA nv portfolio CI
Frequently asked questions about Placebo of Test product
What is Placebo of Test product?
How does Placebo of Test product work?
Who makes Placebo of Test product?
Is Placebo of Test product also known as anything else?
What development phase is Placebo of Test product in?
Related
- Manufacturer: FLUIDDA nv — full pipeline
- Also known as: Placebo inhaler containing HFA propellant resembling the test active inhaler
- Compare: Placebo of Test product vs similar drugs
- Pricing: Placebo of Test product cost, discount & access